Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KYMR

Kymera Therapeutics, Inc.

CIK 0001815442 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$119.35
↑ 0.35 (0.29%)
as of Jul 10, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$9.79B
P/E Ratio
-31.07
EPS
-3.69
Dividend Yield
Not covered
52W Position
89%
Beta
0.96

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
6.36
P/S
190.16
EV/Revenue
187.36
ROE
-20.5%
Valuation data covers 8,503/9,467 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 89%
$36.65$130.05

Latest Financials

2025-12-31 FY
Revenue
$39.21M
Net Income
-$311.35M
Total Assets
$1.74B
Free Cash Flow
-$234.34M

Recent news